Oncode Institute Annual Meeting 2025
-
Registration for the Annual Meeting 2025 is open until 4 June!
Registration for the Annual Meeting 2025 is open until 4 June!
You can now register for our Annual Meeting, taking place on 23 and 24 June 2025, at the De Rijtuigenloods in Amersfoort. We have prepared an exciting programme and look forward to welcoming you!
Practical details
- Date: June 23 and 24
- Location: De Rijtuigenloods, Amersfoort
- Poster Prize: Oncode Institute will be awarding a Poster Prize
- Registration Deadline: 4 June 2025
Scientific Committee
- Jarno Drost
- Wouter de Laat
- Rebekka Schneider
Oncode Institute organization team
- Mariëlle Harlé
- Gerdien Mijnheer
- Colette ten Hove
More information will follow. If you have any questions, please contact us at [email protected].
Who it is for
This is a closed event, exclusive to Oncode Institute Members.
Programme
You can find an overview of the programme below, or you can download the programme.
Monday, 23 June
| 09.00 - 09.45 | Walk in, registration & coffee/tea (wachtkamer 1) |
| 09.15 - 09.35 | Introduction new researchers |
| 09.45 - 10.00 | Welcome and intro technology newsletter by Jan Paul Medema |
| 10.00 - 11.20 | Session I: (4x12 min + 3min Q&A and 1x17 min + 3min Q&A) |
| 10.00 - 10.15 | Exploiting the ubiquitin system to induce organelle-mediated mitotic catastrophe |
| Ilana Berlin (LUMC) | |
| 10.15 - 10.30 | Implementations of nanopore sequencing based diagnostics |
| Carlo Vermeulen (UMCU) | |
| 10.30 - 10.45 | Ex vivo assay to predict effects of paclitaxel treatment on breast tumors |
| Zofia Komar (Erasmus MC) | |
| 10.45 - 11.00 | CIC: The Master Regulator of Resistance to MAPK Pathway Inhibition |
| Joao Manuel (NKI) | |
| 11.00 - 11.20 | Partnership with Cancer Research Horizons, an example |
| Jos Jonkers (NKI) | |
| 11.20 - 11.50 | Coffee break (30min) |
| 11.50-12.50 | Session II: (2x12 min + 3min Q&A and 1x17 min + 3min Q&A) |
| 11.50 - 12.05 | Uncovering enhancer dynamics during lineage reprogramming and leukemogenesis using proximity proteomics |
| Inge de Krijger (RU) | |
| 12.05 - 12.20 | Unlocking the black-box of TIL therapy: Discovery of the goldilocks T-cell state |
| Matthew Hancock (NKI) | |
| 12.20 - 12.50 | Patient Engagement Session |
| Rachel Giles "A scientist's Journey Through Cancer to EU and Global | |
| 12.50 - 13.20 | Lunch (30min) |
| 13.20 - 14.20 | Poster session A (1 hour) incl. lunch |
| 14.20 - 15.30 | Session III: (5x12 min + 3min Q&A) |
| 14.20 - 14.35 | Deciphering fibrotic niches in MPN using NicheSphere: a cellular interaction map of bone marrow fibrosis |
| Hélène Gleitz (Erasmus MC) | |
| 14.35 - 14.50 | An organoid-based multi-omics platform for neoantigen identification and validation enables TCR-T therapy development |
| Sangho Lim (Hubrecht Institute) | |
| 14.50 - 15.05 | Revealing a ‘hidden power’ - 11-oxygenated androgens sustain Androgen Receptor activation and drive advanced prostate cancer progression |
| Emma Minnee (NKI) | |
| 15.05 - 15.20 | Targeting Hijacked Enhancers Driving EVI1 Expression in Leukemia By Inhibition of p300/CBP |
| Dorien Pastoors (Erasmus MC) | |
| 15.20 - 15.35 | Real-Time Mapping of CAR T Cell Signaling at Molecular Resolution |
| Chi Nguyen (AMOLF) | |
| 15.35 - 16.10 | Short break (35min) |
| 16.10 - 17.10 | Session IV (4x12 min + 3min Q&A) |
| 16.10 - 16.25 | CycloSELs: Massive screening of fully synthetic macrocycles using Self-Encoded Libraries |
| José Miguel Mata (LU) | |
| 16.25 - 16.40 | A Next-generation CRISPR cure for pediatric cancer |
| Maarten Geurts (Prinses Máxima Centrum Centrum) | |
| 16.40 - 16.55 | Fibroblast patterning induces metastatic cell states at the earliest stages of colon cancer |
| Julian Buissant des Amorie (UMCU) | |
| 16.55 - 17.10 | Dissecting the role of cancer cell-intrinsic cMET activation on immunomodulation in breast cancer |
| Annemieke Bouwman (NKI) | |
| 17.10 | Summary and closing day 1 |
| 17.15 | End of conference day 1 |
| 17.15 - 18.30 | Networking drinks and posters |
Tuesday, 24 June
| 08.45 - 09.45 | walk in, registration & coffee/tea |
| 09.45 - 09.50 | Welcome by Scientific Committee |
| 09.50 - 11.10 | Session V: (5x12 min+ 3minQ&A) |
| 09.50 - 10.05 | Exploring human adrenocortical carcinoma development and progression using organoid technology |
| Jelte van der Vaart (UMCU) | |
| 10.05 - 10.20 | Uncoupling early immune dynamics in tumor tissue and blood in cSCC patients treated with ICB |
| Mercedes Machuca-Ostos (NKI) | |
| 10.20 - 10.35 | Identification of (ultra-)rare functional promoter mutations in cancer using sequence-based deep learning models |
| Tijs van Lieshout (UMCG) | |
| 10.35 - 10.50 | Lipid and Adenosime metabolism pathways fuel immunosuppression in glioblastoma |
| Nicolas Camviel (NKI) | |
| 10.50 - 11.10 | Oncode Accelerator: Current status and future perspectives |
| Mark Krul (Oncode Accelerator) | |
| 11.10 - 11.40 | Short break (30min) |
| 11.40 - 12.45 | Session VI: (4x12 min+ 3minQ&A) |
| 11.40 - 11.55 | Exploring the Dark Proteome in Ewing Sarcoma: Translation of Fusion-Driven Unannotated Genes |
| Luuk Broeils (Prinses Máxima Centrum) | |
| 11.55 - 12.10 | Cytotoxic ILC-1 cells determine outcome of PD-(L)1 blockade in microsatellite instable cancers |
| Paula van Royen (NKI) | |
| 12.10 - 12.25 | How Cancer-Associated Fibroblasts Drive Invasion in Colorectal Cancer |
| Ciro Longobardi (AUMC) | |
| 12.25 - 12.40 | FTSJ1 promotes W>F substitutants to boost adaptability to anti-tumor immunity |
| Amos Fumagalli (NKI) | |
| 12.40 - 12.45 | Launch new Oncode Institute website - Thomsy Jongepier |
| 12.45 - 13.15 | Lunch & networking (30 min) |
| 13.15 - 14.15 | Poster session B (1 hour) incl. lunch |
| 14.15 - 15.05 | Session VII: (4x12 min+ 3minQ&A) |
| 14.15 - 14.30 | Replication Stress-Induced Chromatin Loops Protect Forks and Maintain Genome Stability |
| Vincent Gaggioli (Erasmus MC) | |
| 14.30 - 14.45 | Heterotypic CD8 T cell clusters isolated from clinical samples are biologically distinct and enriched for antitumor activity |
| Johanna Veldman (NKI) | |
| 14.45 - 15.05 | The value of national WGS data for cancer patients now and tomorrow |
| Joep de Ligt (Hartwig Medical Foundation) | |
| 15.05 - 15.40 | Short break (35min) |
| 15.40 - 16.35 | Session VIII: (4x12min + 3minQ&A) |
| 15.40 - 15.55 | Unravelling heterogeneity in response to engineered T-cell immunotherapy using cancer patients derived organoids |
| Britt Vervoort (Prinses Máxima Centrum) | |
| 15.55 - 16.10 | MYC promotes lobuloalveologenesis and mammary tumorigenesis in male mice |
| Emilia Pulver (NKI) | |
| 16.10 - 16.25 | Limb multipotency coincides with the pre-emptive disassembly of genome-lamina interactions |
| Isabel Guerreiro (Hubrecht Institute) | |
| 16.25 - 16.35 | Community Committee |
| 16.35 - 16.45 | Poster Prizes |
| 16.45 - 16.50 | Summary and closing day 2 |
| 16.50 - 18.00 | Networking drinks and posters |
| 18.00 | End of conference day 2 |
Registration
To register, please fill in the form below: